

United Health Earnings Setback; Eli Lilly Soars; TSMC Beats Forecast
Apr 17, 2025
A significant setback hits United Health, as its earnings forecast is slashed amid rising Medicare care needs. Meanwhile, Eli Lilly celebrates a breakthrough with its weight-loss drug, making waves in the pharmaceutical industry. TSMC also exceeds expectations, projecting robust sales driven by AI growth. Hertz bounces back on news of a major hedge fund investment, highlighting the potential for recovery in the car rental sector. The stock market's volatility continues to captivate investors!
AI Snips
Chapters
Transcript
Episode notes
UnitedHealth's Rare Guidance Cut
- UnitedHealth cut its full-year adjusted EPS forecast due to higher-than-expected medical costs and changes in its Optum business.
- The company typically conservatively forecasts and rarely lowers guidance, making this cut a significant indicator.
Hertz's Ackman-Fueled Surge & Anecdote
- Hertz shares surged following Bill Ackman's Pershing Square taking nearly a 20% stake and becoming the second largest shareholder.
- Lisa shares personal experience as a Hertz Gold customer appreciating the service despite past billing frustrations.
Eli Lilly's Oral GLP-1 Breakthrough
- Eli Lilly's oral GLP-1 drug showed weight loss comparable to popular shots and also significantly lowered blood sugar levels.
- The pill format offers an alternative to injections with notable efficacy, impacting the competitive landscape for weight loss drugs.